No new digest content identified.
National Health Commission of the People’s Republic of China [to 17 Apr 2021]
April 17: Daily briefing on novel coronavirus cases in China
On April 16, 31 provincial-level regions and the Xinjiang Production and Construction Corps on the Chinese mainland reported 15 new cases of confirmed infections.
Director of China CDC criticizes misleading accounts
Gao Fu, director-general of Chinese Center for Disease Control and Prevention, has made it clear that boosting vaccine protection is a question of global concern, not only for China.
During a forum held on Saturday, Gao proposed upgrading immunization procedures or mixing doses using different technologies as ways to further improve vaccine effectiveness.
However, some media reports have misinterpreted his statement as claiming that Chinese vaccines do not have high efficacy rates, the scientist said.
“They (media reports) are misleading and have taken my words out of context,” Gao said during an interview with online media outlet Guancha.cn on Sunday.
“The World Health Organization requires all COVID-19 vaccines to have an efficacy rate of 50 percent or higher, and to be effective in preventing severe infections and deaths. All approved vaccines meet these standards,” he said…
COVID-19 herd immunity feasible in China, experts say
Stronger effort needed to boost the public’s confidence about getting shots
Speeding up COVID-19 vaccinations to reach herd immunity in China will be a challenging but feasible task, health experts have said, calling for stronger efforts to raise public awareness about vaccines and make the inoculation process more convenient and considerate.
Vaccination distribution across the country has been gaining momentum in recent weeks, with nearly 165 million doses administered and daily inoculations exceeding 6 million doses on several occasions, official data showed.
But reaching the estimated herd immunity threshold of 70 to 80 percent is a formidable endeavor and will require innovative and concerted efforts, Gao Fu, director-general of the Chinese Center for Disease Control and Prevention, said during a forum in Chengdu, capital of Sichuan province, on Saturday.
“The mass vaccination drive faces constraints posed by limited inoculation sites and a lack of understanding of the significance and urgency to obtain vaccines, among other factors,” he said.
Public health experts have said that the country hopes to vaccinate 40 percent of the population by June or July, and 70 percent by the end of this year or early next year…
National Medical Products Administration – PRC [to 17 Apr 2021]
China approves new COVID-19 vaccine for clinical trials
The new recombinant COVID-19 vaccine, developed by the National Vaccine & Serum Institute, a R&D center of Sinopharm’s bioscience subsidiary the China National Biotec Group (CNBG), got approval from the National Medical Products Administration on April 9, the CNBG said on its official Weibo account on Saturday.